Filter Results :

Your search for Biotech and Diagnostics returned 12 reports

Sort by


Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

05 Feb 2015  |  Published by:  CurrentPartnering
The Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the distribution partnering agreements entered into by the worlds leading biopharma companies. The report provides a detailed understan...

$ 3,495.00

Read More

Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

05 Feb 2015  |  Published by:  CurrentPartnering
The Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading healthcare companies. Revis...

$ 1,995.00

Read More

Licensing Terms and Agreements in Pharma, Biotech and Diagnostics

05 Feb 2015  |  Published by:  CurrentPartnering
The Licensing Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the licensing deals and agreements entered into by the worlds leading life science companies. The report provides a detailed understand and analysis of...

$ 3,495.00

Read More

Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

01 Dec 2014  |  Published by:  CurrentPartnering
 The Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements entered into by the world’s biopharma companies. The report provides a detailed ...

$ 3,295.00

Read More

Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

01 Dec 2014  |  Published by:  CurrentPartnering
The Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter royalty financing deals. -Comprehensive directory of royalty financing deals since 2007 -Royalty financing contract documents -Roy...

$ 1,995.00

Read More

Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics

01 Dec 2014  |  Published by:  CurrentPartnering
The Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the asset purchase agreements entered into by the worlds leading biopharma companies. The report provides a detailed understand and anal...

$ 2,995.00

Read More

Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

01 Nov 2014  |  Published by:  CurrentPartnering
The Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies. The report provides a ...

$ 2,995.00

Read More

Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics

01 Oct 2014  |  Published by:  CurrentPartnering
The Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the joint venture partnering agreements entered into by the worlds leading healthcare companies. This new 1st edition, includes: Trends in join...

$ 1,995.00

Read More

RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) - Global Forecast to 2019

26 Sep 2014  |  Published by:  MarketsandMarkets
Report Description The global transcriptomics market is expected to grow at a CAGR of 13.7% during the forecast period of 2014 to 2019 and is estimated to be worth $3,773.0 million by 2019. The transcriptomics market has blatantly grown in the past few years primarily due to the increasing ...

$ 4,650.00

Read More

Collaborative R&D Terms and Agreements in Pharma, Biotech and Diagnostics

01 Aug 2014  |  Published by:  CurrentPartnering
The Collaborative R&D Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the collaborative R&D deals and agreements entered into by the worlds leading life science companies. The report provides a detailed under...

$ 2,995.00

Read More

Co-Development Terms and Agreements in Pharma, Biotech and Diagnostics

01 Aug 2014  |  Published by:  CurrentPartnering
The Co-development Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-development deals and agreements entered into by the worlds leading life science companies. The report provides a detailed understand and anal...

$ 2,995.00

Read More

Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

01 Apr 2014  |  Published by:  CurrentPartnering
The Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the asset purchase agreements entered into by the worlds leading biopharma companies. The report provides a detailed understand and anal...

$ 2,995.00

Read More
Total 12 records.